Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
European Neurology|August 8, 2016
Quantification of Gait Abnormalities in Healthy-Looking Multiple Sclerosis Patients (with Expanded Disability Status Scale 0-1.5)Klara Novotna, Lukas Sobisek, Dana Horakova, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|May 24, 2019
One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 NeovascularizationJan Ernest, Katerina Manethova, Petr Kolar, et al.Neuropsychiatric Disease and Treatment|September 21, 2018
Do eyes with and without optic neuritis in multiple sclerosis age equally?Jana Lizrova Preiningerova, Anna Grishko, Lukas Sobisek, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 15, 2021
The clinical and paraclinical correlates of employment status in multiple sclerosisBarbora Srpova, Lukas Sobisek, Klara Novotna, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2016
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?Tomas Uher, Eva Havrdova, Lukas Sobisek, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 28, 2018
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple SclerosisTomas Uher, Jan Krasensky, Lukas Sobisek, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2016
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosisTomas Uher, Manuela Vaneckova, Lukas Sobisek, et al.Multiple Sclerosis and Related Disorders|June 24, 2021
Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groupsZbysek Pavelek, Michal Novotny, Ondrej Soucek, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 3, 2017
A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative StudyTomas Uher, Jan Krasensky, Manuela Vaneckova, et al.Annals of Clinical and Translational Neurology|January 30, 2018
Cognitive clinico-radiological paradox in early stages of multiple sclerosisTomas Uher, Jan Krasensky, Lukas Sobisek, et al.Pageof 2